BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 8348847)

  • 1. Prognostic value of tumor "budding" in patients with colorectal cancer.
    Hase K; Shatney C; Johnson D; Trollope M; Vierra M
    Dis Colon Rectum; 1993 Jul; 36(7):627-35. PubMed ID: 8348847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor budding at the invasive margin can predict patients at high risk of recurrence after curative surgery for stage II, T3 colon cancer.
    Tanaka M; Hashiguchi Y; Ueno H; Hase K; Mochizuki H
    Dis Colon Rectum; 2003 Aug; 46(8):1054-9. PubMed ID: 12907899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic value of histological findings indicating biological attitude at the invasive front of rectal cancer].
    Hase K
    Nihon Geka Gakkai Zasshi; 1993 Sep; 94(9):1022-32. PubMed ID: 8246866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor budding as an index to identify high-risk patients with stage II colon cancer.
    Nakamura T; Mitomi H; Kanazawa H; Ohkura Y; Watanabe M
    Dis Colon Rectum; 2008 May; 51(5):568-72. PubMed ID: 18286339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
    Jäger T; Neureiter D; Fallaha M; Schredl P; Kiesslich T; Urbas R; Klieser E; Holzinger J; Sedlmayer F; Emmanuel K; Dinnewitzer A
    Strahlenther Onkol; 2018 Nov; 194(11):991-1006. PubMed ID: 30069738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival in patients with large-bowel cancer. A population-based investigation from the Melbourne Colorectal Cancer Study.
    Kune GA; Kune S; Field B; White R; Brough W; Schellenberger R; Watson LF
    Dis Colon Rectum; 1990 Nov; 33(11):938-46. PubMed ID: 2226081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors and the role of adjuvant chemotherapy in post-curative surgery for Dukes B and C colon cancers and survival outcomes: a Malaysian experience.
    Hassan AS; Naicker M; Yusof KH; Wan Ishak WZ
    Asian Pac J Cancer Prev; 2015; 16(6):2237-43. PubMed ID: 25824744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Budding is useful to select high-risk patients in stage II well-differentiated or moderately differentiated colon adenocarcinoma.
    Okuyama T; Nakamura T; Yamaguchi M
    Dis Colon Rectum; 2003 Oct; 46(10):1400-6. PubMed ID: 14530682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Number and size of lymph nodes recovered from dukes B rectal cancers: correlation with prognosis and histologic antitumor immune response.
    Murphy J; Pocard M; Jass JR; O'Sullivan GC; Lee G; Talbot IC
    Dis Colon Rectum; 2007 Oct; 50(10):1526-34. PubMed ID: 17828403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multivariate regression analysis of recurrence following curative surgery for colorectal cancer].
    Liang JL; Wan DS; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Wu XJ
    Ai Zheng; 2004 May; 23(5):564-7. PubMed ID: 15142455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of microscopic extranodal tumor deposits on the outcome of patients with rectal cancer.
    Prabhudesai A; Arif S; Finlayson CJ; Kumar D
    Dis Colon Rectum; 2003 Nov; 46(11):1531-7. PubMed ID: 14605575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verification of a new clinicopathologic staging system for colorectal adenocarcinoma.
    Michelassi F; Ayala JJ; Balestracci T; Goldberg R; Chappell R; Block GE
    Ann Surg; 1991 Jul; 214(1):11-8. PubMed ID: 2064465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Fluorouracil-interferon-alpha 2b adjuvant treatment of Dukes C colorectal cancer.
    Frasci G; Leone F; Monaco M; Cremone L; Sapio U; Faiella F; Espinosa A; Persico G
    Dis Colon Rectum; 1994 Jul; 37(7):643-50. PubMed ID: 8026229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of pathologic margins and Dukes' stage to local recurrence in colorectal carcinoma.
    Devereux DF; Deckers PJ
    Am J Surg; 1985 Mar; 149(3):323-6. PubMed ID: 3976986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity of tumor budding and its prognostic implications in invasive colon carcinoma.
    Park KJ; Choi HJ; Roh MS; Kwon HC; Kim C
    Dis Colon Rectum; 2005 Aug; 48(8):1597-602. PubMed ID: 15937624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of high and intermediate ligation on survival and recurrence rates following curative resection of colorectal cancer.
    Slanetz CA; Grimson R
    Dis Colon Rectum; 1997 Oct; 40(10):1205-18; discussion 1218-9. PubMed ID: 9336116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of curative resection of "minimally invasive" colorectal cancer.
    Hase K; Shatney CH; Mochizuki H; Johnson DL; Tamakuma S; Vierra M; Trollope M
    Dis Colon Rectum; 1995 Jan; 38(1):19-26. PubMed ID: 7813339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramural spread of colon carcinoma. A pathologic study.
    Hughes TG; Jenevein EP; Poulos E
    Am J Surg; 1983 Dec; 146(6):697-9. PubMed ID: 6650750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinomas of the colon and rectum. A comparison of staging classifications.
    Nathanson SD; Schultz L; Tilley B; Kambouris A
    Am Surg; 1986 Aug; 52(8):428-33. PubMed ID: 3729181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Budding (sprouting) as a useful prognostic marker in colorectal mucinous carcinoma.
    Okuyama T; Oya M; Yamaguchi M
    Jpn J Clin Oncol; 2002 Oct; 32(10):412-6. PubMed ID: 12451038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.